Jay S. Stout, Chief Technology Officer at Immunovant, Inc. (IMVT), sold 10,132 shares at $24.83 ($252K) on 2026-04-08, disclosed to the SEC on 2026-04-10.
Seasonal sale ($252k) by Chief Technology Officer — this insider has traded IMVT in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.83 | 1,518 | $38K | 15.0% |
| 2 | $24.83 | 8,614 | $214K | 85.0% |
| Total | $24.83 avg | 10,132 | $252K | 100% |
| Filing → |
| IMVT | SELL | 2026-06-26 | $1.5M | — | Filing → |
| IMVT | SELL | 2026-04-24 | $82K | — | Filing → |
| IMVT | SELL | 2026-01-23 | $51K | — | Filing → |